Atea Pharmaceuticals Inc (AVIR)
3.69
-0.01
(-0.27%)
USD |
NASDAQ |
Apr 25, 16:00
3.69
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 351.37M |
Date | Value |
---|---|
September 30, 2021 | 207.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
207.82M
Minimum
Sep 2021
351.37M
Maximum
Dec 2021
279.59M
Average
279.59M
Median
Revenue (TTM) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.202M |
IGC Pharma Inc | 1.216M |
NovaBay Pharmaceuticals Inc | 14.73M |
Protalix BioTherapeutics Inc | 65.49M |